Random

FDA

MedShadow's Top 10 Stories of 2018 (FDA)

MedShadow Articles

MedShadow’s Top 10 Stories of 2018 (FDA)

Required Postmarketing Studies For New Drugs

Required Postmarketing Studies For New Drugs

Synthroid

Quick Hits: Synthroid Questions, Bogus Cancer Treatments & More

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

Issues Related to Healthcare News FDA

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

Episode 19: When The FDA Assesses An Opioid Delivery Method

Episode 19: When The FDA Assesses An Opioid Delivery Method

FDA: Why Drugs Should Take A Long Time To Get To Market

FDA: Why Drugs Should Take A Long Time To Get To Market

Suzanne B. Robotti

Health Pulse FDA

Could the FDA Be Doing More to Curb Teen E-Cig, Vaping Use?

FDA Requiring Long-Term Research of OxyContin Use

FDA Requiring Long-Term Research of OxyContin Use

Suzanne B. Robotti

Light Therapy May Ease Cancer Symptoms

News FDA Quick Hits

Quick Hits: Light Therapy May Ease Cancer Symptoms

Quick Hits: FDA About MRI Contrast Agent Problem And More

Quick Hits: FDA About MRI Contrast Agent Problem And More

The FDA Has It Wrong on Kratom: How the Herb is Helping People

Transforming U.S. Drug Policy, equitable healthcare

MedShadow Articles

Opinion: Transforming U.S. Drug Policy for Better Drug Safety

Suzanne B. Robotti

What to Know About the Right to Try Law in 2024

What to Know About the Right to Try Law in 2024

MedShadow Articles

Choices For The Terminally Ill: FDA’S Expanded Access Program Or Right To Try Act?

Jessica DiGiacinto

NSAID Side Effects Lead To Stronger FDA Warnings

NSAID Side Effects Lead To Stronger FDA Warnings

Study Questions Safety of Silicone Breast Implants; FDA Disputes Findings

Study Questions Safety of Silicone Breast Implants

News FDA Quick Hits

Quick Hits: FDA Threatens E-Cig Manufacturers & More

FDA Warning: Side Effects of Injectable Silicone

FDA Warning: Side Effects of Injectable Silicone

Why Are We Wasting Medical Research Money?

Healthy Skeptic new

Why Are We Wasting Medical Research Money?

Suzanne B. Robotti

FDA Gives Singulair the Thumbs Down for OTC

FDA Gives Singulair the Thumbs Down for OTC

FDA Approves Muscular Dystrophy Drug

Issues Related to Healthcare News FDA Quick Hits

FDA Approves Muscular Dystrophy Drug

Load More

x

x